Mometasone Furoate
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for .MOMETASONE FUROATE ointment, for topical useInitial U.S. Approval: 1987
Approved
Approval ID
43a91066-1d85-4f67-9856-a11c1bb2b22b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 18, 2023
Manufacturers
FDA
Bryant Ranch Prepack
DUNS: 171714327
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Mometasone Furoate
PRODUCT DETAILS
NDC Product Code63629-8683
Application NumberANDA076067
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateJanuary 20, 2022
Generic NameMometasone Furoate
INGREDIENTS (7)
PROPYLENE GLYCOL MONOSTEARATEInactive
Code: MZM1I680W0
Classification: IACT
MOMETASONE FUROATEActive
Quantity: 1 mg in 1 g
Code: 04201GDN4R
Classification: ACTIB
HEXYLENE GLYCOLInactive
Code: KEH0A3F75J
Classification: IACT
PHOSPHORIC ACIDInactive
Code: E4GA8884NN
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
WHITE WAXInactive
Code: 7G1J5DA97F
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT